NCT04126759View on ClinicalTrials.gov

Calibration of a Non-invasive Glucose Measurement Device and Assessment of Its Performance in the Hypoglycemic Range in Patients With Type 1 Diabetes

NACompletedINTERVENTIONAL
Enrollment

15

Participants

Timeline

Start Date

July 1, 2019

Primary Completion Date

January 31, 2020

Study Completion Date

January 31, 2020

Conditions
Diabetes Mellitus
Interventions
DEVICE

P0.3

Subjects will perform daily measurements on the IMD (Prototype 0.3) for 35 days.

Trial Locations (1)

2820

Steno Diabetes Center Copenhagen (SDCC), Gentofte Municipality

All Listed Sponsors
collaborator

Steno Diabetes Center Copenhagen

OTHER

lead

RSP Systems A/S

INDUSTRY

NCT04126759 - Calibration of a Non-invasive Glucose Measurement Device and Assessment of Its Performance in the Hypoglycemic Range in Patients With Type 1 Diabetes | Biotech Hunter | Biotech Hunter